AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
CHRONIC LYMPHOCYTIC-LEUKEMIA B-CELLS EXPRESS RESTRICTED SETS OF MUTATED AND UNMUTATED ANTIGEN RECEPTORS
Authors: FAIS F GHIOTTO F HASHIMOTO S SELLARS B VALETTO A ALLEN SL SCHULMAN P VINCIGUERRA VP RAI K RASSENTI LZ KIPPS TJ DIGHIERO G SCHROEDER HW FERRARINI M CHIORAZZI N
Citation: F. Fais et al., CHRONIC LYMPHOCYTIC-LEUKEMIA B-CELLS EXPRESS RESTRICTED SETS OF MUTATED AND UNMUTATED ANTIGEN RECEPTORS, The Journal of clinical investigation, 102(8), 1998, pp. 1515-1525
A RANDOMIZED CONTROLLED TRIAL OF FILGRASTIM DURING REMISSION INDUCTION AND CONSOLIDATION CHEMOTHERAPY FOR ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - CALGB STUDY-9111
Authors: LARSON RA DODGE RK LINKER CA STONE RM POWELL BL LEE EJ SCHULMAN P DAVEY FR FRANKEL SR BLOOMFIELD CD GEORGE SL SCHIFFER CA
Citation: Ra. Larson et al., A RANDOMIZED CONTROLLED TRIAL OF FILGRASTIM DURING REMISSION INDUCTION AND CONSOLIDATION CHEMOTHERAPY FOR ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - CALGB STUDY-9111, Blood, 92(5), 1998, pp. 1556-1564
A DOUBLE-BLIND, RANDOMIZED STUDY OF 2 DIFFERENT DOSAGE REGIMENS OF INTRAVENOUS DOLASETRON IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN CHEMOTHERAPY
Authors: KASIMIS BS TAPAZOGLOU E SCHULMAN P STEWART WH HAHNE WF CRAMER MB
Citation: Bs. Kasimis et al., A DOUBLE-BLIND, RANDOMIZED STUDY OF 2 DIFFERENT DOSAGE REGIMENS OF INTRAVENOUS DOLASETRON IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN CHEMOTHERAPY, Cancer investigation, 15(4), 1997, pp. 304-310
CLONAL EXPANSION WITHIN THE CD4(-CELL SUBSETS IN CHRONIC LYMPHOCYTIC-LEUKEMIA()CD57(+) AND CD8(+)CD57(+) T)
Authors: SERRANO D MONTEIRO J ALLEN SL KOLITZ J SCHULMAN P LICHTMAN SM BUCHBINDER A VINCIGUERRA VP CHIORAZZI N GREGERSEN PK
Citation: D. Serrano et al., CLONAL EXPANSION WITHIN THE CD4(-CELL SUBSETS IN CHRONIC LYMPHOCYTIC-LEUKEMIA()CD57(+) AND CD8(+)CD57(+) T), The Journal of immunology, 158(3), 1997, pp. 1482-1489
IN-VIVO LOSS OF SURFACE-MEMBRANE CD5 EXPRESSION BY A B-TYPE CHRONIC LYMPHOCYTIC-LEUKEMIA - MOLECULAR AND CELLULAR EVIDENCE FOR VARIABILITY IN CD5 EXPRESSION
Authors: DAMLE RN HASHIMOTO S DONO H ALLEN SL SCHULMAN P VINCIGUERRA VP FERRARINI M CHIORAZZI N
Citation: Rn. Damle et al., IN-VIVO LOSS OF SURFACE-MEMBRANE CD5 EXPRESSION BY A B-TYPE CHRONIC LYMPHOCYTIC-LEUKEMIA - MOLECULAR AND CELLULAR EVIDENCE FOR VARIABILITY IN CD5 EXPRESSION, Blood, 90(10), 1997, pp. 3684-3684
COMPARISON OF CLINICAL COURSE OF CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS BASED ON EXPRESSION OF SURFACE IMMUNOGLOBULINS
Authors: WASIL T ZUCKERMAN D BUCHBINDER A BUDMAN DR KOLITZ J LICHTMAN SM ALLEN SL SCHULMAN P VINCIGUERRA V CHIORAZZI N
Citation: T. Wasil et al., COMPARISON OF CLINICAL COURSE OF CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS BASED ON EXPRESSION OF SURFACE IMMUNOGLOBULINS, Blood, 90(10), 1997, pp. 4116-4116
ACQUIRED FACTOR-VIII INHIBITORS - SUCCESSFUL TREATMENT WITH AN ORAL OUTPATIENT REGIMEN
Authors: BAYER R LOSCALZO J ALLEN SL WASIL T LICHTMAN SM KOLITZ J FETTEN J SCHULMAN P
Citation: R. Bayer et al., ACQUIRED FACTOR-VIII INHIBITORS - SUCCESSFUL TREATMENT WITH AN ORAL OUTPATIENT REGIMEN, Blood, 90(10), 1997, pp. 152-152
POST REMISSION THERAPY IN OLDER PATIENTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) - A RANDOMIZED TRIAL OF MITOXANTRONE INTERMEDIATE DOSE CYTARABINE-V STANDARD-DOSE CYTARABINE (CALBG-8923)/
Authors: STONE RM BERG DT GEORGE SL DODGE RK PACIUCCI PA SCHULMAN P LEE EJ MOORE JO POWELL BL SCHIFFER CA
Citation: Rm. Stone et al., POST REMISSION THERAPY IN OLDER PATIENTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) - A RANDOMIZED TRIAL OF MITOXANTRONE INTERMEDIATE DOSE CYTARABINE-V STANDARD-DOSE CYTARABINE (CALBG-8923)/, Blood, 90(10), 1997, pp. 2255-2255
DIFFERENTIAL INDUCTION OF CD22 EXPRESSION IN SIGM-CLL PATIENTS BY T-DEPENDENT AND T-INDEPENDENT STIMULI( AND SIGG+ B)
Authors: DAMLE RN ALLEN SL SCHULMAN P VINCIGUERRA VP CHIORAZZI N
Citation: Rn. Damle et al., DIFFERENTIAL INDUCTION OF CD22 EXPRESSION IN SIGM-CLL PATIENTS BY T-DEPENDENT AND T-INDEPENDENT STIMULI( AND SIGG+ B), Blood, 90(10), 1997, pp. 2331-2331
CLINICAL AND MORPHOLOGICAL FEATURES OF CASES OF TRISOMY-13 IN ACUTE NONLYMPHOCYTIC LEUKEMIA
Authors: SONI M BRODY J ALLEN SL SCHULMAN P KOLITZ J RAI K BROOME JD KODURU PRK
Citation: M. Soni et al., CLINICAL AND MORPHOLOGICAL FEATURES OF CASES OF TRISOMY-13 IN ACUTE NONLYMPHOCYTIC LEUKEMIA, Leukemia, 10(4), 1996, pp. 619-623
PHASE-I STUDY OF HIGH-DOSE ETOPOSIDE PHOSPHATE IN MAN
Authors: FIELDS SZ BUDMAN DR YOUNG RR KREIS W INGRAM R SCHULMAN P CHERNY RC WRIGHT J BEHR J SNOW C SCHACTER LP
Citation: Sz. Fields et al., PHASE-I STUDY OF HIGH-DOSE ETOPOSIDE PHOSPHATE IN MAN, Bone marrow transplantation, 18(5), 1996, pp. 851-856
RETENTION OF IRON AND CHROMIUM BY AN ANION-EXCHANGE RESIN UNDER DECONTAMINATION CONDITIONS
Authors: CORTI HR GOMEZ DG DEBLANCO EK REBAGLIATI RAJ SCHULMAN P
Citation: Hr. Corti et al., RETENTION OF IRON AND CHROMIUM BY AN ANION-EXCHANGE RESIN UNDER DECONTAMINATION CONDITIONS, Journal of nuclear materials, 229(1), 1996, pp. 132-138
A PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF INTRAVENOUS PILOCARPINE IN HUMANS (VOL 74, PG 1845, 1995)
Authors: TANZER JM KRAMER PA SCHULMAN P WILLARD AK
Citation: Jm. Tanzer et al., A PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF INTRAVENOUS PILOCARPINE IN HUMANS (VOL 74, PG 1845, 1995), Journal of dental research, 75(1), 1996, pp. 616-616
EXAMPLES OF IN-VIVO ISOTYPE CLASS SWITCHING IN IGM(-LEUKEMIA B-CELLS() CHRONIC LYMPHOCYTIC)
Authors: FAIS F SELLARS B GHIOTTO F YAN XJ DONO M ALLEN SL BUDMAN D DITTMAR K KOLITZ J LICHTMAN SM SCHULMAN P SCHUSTER M VINCIGUERRA VP RAI KT STEVENSON FK GREGERSEN PK FERRARINI M CHIORAZZI N
Citation: F. Fais et al., EXAMPLES OF IN-VIVO ISOTYPE CLASS SWITCHING IN IGM(-LEUKEMIA B-CELLS() CHRONIC LYMPHOCYTIC), The Journal of clinical investigation, 98(7), 1996, pp. 1659-1666
PARTIAL TANDEM DUPLICATION OF ALL1 AS A RECURRENT MOLECULAR DEFECT INACUTE MYELOID-LEUKEMIA WITH TRISOMY-11
Authors: CALIGIURI MA STROUT MP SCHICHMAN SA MROZEK K ARTHUR DC HERZIG GP BAER MR SCHIFFER CA HEINONEN K KNUUTILA S NOUSIAINEN T RUUTU T BLOCK AW SCHULMAN P PEDERSENBJERGAARD J CROCE CM BLOOMFIELD CD
Citation: Ma. Caligiuri et al., PARTIAL TANDEM DUPLICATION OF ALL1 AS A RECURRENT MOLECULAR DEFECT INACUTE MYELOID-LEUKEMIA WITH TRISOMY-11, Cancer research, 56(6), 1996, pp. 1418-1425
LATE APPEARANCE OF THE PHILADELPHIA (PH(1)) CHROMOSOME IN ACUTE LYMPHOCYTIC-LEUKEMIA
Authors: BAYER R KOLITZ JE ALLEN SL SCHULMAN P BRODY J KODURU P
Citation: R. Bayer et al., LATE APPEARANCE OF THE PHILADELPHIA (PH(1)) CHROMOSOME IN ACUTE LYMPHOCYTIC-LEUKEMIA, Blood, 88(10), 1996, pp. 3332-3332
DEL(9Q) IN MYELOID NEOPLASIAS - CLINICAL AND HEMATOLOGIC FEATURES
Authors: KOLITZ JE SONI M BRODY J SCHULMAN P BROOME J KODURU P
Citation: Je. Kolitz et al., DEL(9Q) IN MYELOID NEOPLASIAS - CLINICAL AND HEMATOLOGIC FEATURES, Blood, 88(10), 1996, pp. 3357-3357
COMORBIDITY AND AGE AS RISK-FACTORS FOR SURVIVAL IN DE-NOVO ACUTE-LEUKEMIA
Authors: LICHTMAN SM KOLITZ J CIRRONE K ZAHEER W SPINEK K WEISMAN A SCHULMAN P
Citation: Sm. Lichtman et al., COMORBIDITY AND AGE AS RISK-FACTORS FOR SURVIVAL IN DE-NOVO ACUTE-LEUKEMIA, Blood, 88(10), 1996, pp. 3390-3390
INTENSIVE DOXORUBICIN VINCRISTINE INDUCTION FOLLOWED BY HIGH-DOSE CYCLOPHOSPHAMIDE GCSF INTENSIFICATION IN PATIENTS WITH ANAPLASTIC LARGE-CELL LYMPHOMA - HODGKINS-LIKE/
Authors: BAYER R ALLEN SL BUCHBINDER A LICHTMAN S SCHULMAN P
Citation: R. Bayer et al., INTENSIVE DOXORUBICIN VINCRISTINE INDUCTION FOLLOWED BY HIGH-DOSE CYCLOPHOSPHAMIDE GCSF INTENSIFICATION IN PATIENTS WITH ANAPLASTIC LARGE-CELL LYMPHOMA - HODGKINS-LIKE/, Blood, 88(10), 1996, pp. 3447-3447
CHRONIC NEUTROPHILIC LEUKEMIA WITH TRANSFORMATION TO BLAST CRISIS ANDASSOCIATED CLONAL CYTOGENETIC EVOLUTION
Authors: WASIL T FETTEN J BAYER R ALLEN S SCHULMAN P
Citation: T. Wasil et al., CHRONIC NEUTROPHILIC LEUKEMIA WITH TRANSFORMATION TO BLAST CRISIS ANDASSOCIATED CLONAL CYTOGENETIC EVOLUTION, Blood, 88(10), 1996, pp. 3577-3577
EVIDENCE FOR PROGENITORS OF CHRONIC LYMPHOCYTIC-LEUKEMIA B-CELLS THATUNDERGO INTRACLONAL DIFFERENTIATION AND DIVERSIFICATION
Authors: DONO M HASHIMOTO S FAIS F TREJO V ALLEN SL LICHTMAN SM SCHULMAN P VINCIGUERRA VP SELLARS B GREGERSEN PK FERRARINI M CHIORAZZI N
Citation: M. Dono et al., EVIDENCE FOR PROGENITORS OF CHRONIC LYMPHOCYTIC-LEUKEMIA B-CELLS THATUNDERGO INTRACLONAL DIFFERENTIATION AND DIVERSIFICATION, Blood, 87(4), 1996, pp. 1586-1594
NO INCREASED RISK OF TAXOL TOXICITY ZN OLDER PATIENTS
Authors: LICHTMAN SM ZAHEER W GAL D LOVECCHIO J DEMARCO LC SCHULMAN P BUDMAN DR TAIBBI R FENTON C VINCIGUERRA V
Citation: Sm. Lichtman et al., NO INCREASED RISK OF TAXOL TOXICITY ZN OLDER PATIENTS, Journal of the American Geriatrics Society, 44(4), 1996, pp. 472-474
ABSENCE OF SOMATIC CHANGES IN P21 GENE IN NON-HODGKINS-LYMPHOMA AND CHRONIC MYELOGENOUS LEUKEMIA
Authors: GONG JZ ZHOU H HU Z SCHULMAN P VINCEGUERRA V BROOME JD KODURU P
Citation: Jz. Gong et al., ABSENCE OF SOMATIC CHANGES IN P21 GENE IN NON-HODGKINS-LYMPHOMA AND CHRONIC MYELOGENOUS LEUKEMIA, Hematologic pathology, 9(3-4), 1995, pp. 171-177
METATRAITS AND COGNITIVE ASSESSMENT - APPLICATION TO ATTRIBUTIONAL STYLE AND DEPRESSIVE SYMPTOMS
Authors: HAAGA DAF AHRENS AH SCHULMAN P SELIGMAN MEP DERUBEIS RJ MINARIK ML
Citation: Daf. Haaga et al., METATRAITS AND COGNITIVE ASSESSMENT - APPLICATION TO ATTRIBUTIONAL STYLE AND DEPRESSIVE SYMPTOMS, Cognitive therapy and research, 19(1), 1995, pp. 121-142
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER INITIAL CHEMOTHERAPY FOR ELDERLY PATIENTS WITH PRIMARY ACUTE MYELOGENOUS LEUKEMIA
Authors: STONE RM BERG DT GEORGE SL DODGE RK PACIUCCI PA SCHULMAN P LEE EJ MOORE JO POWELL BL SCHIFFER CA
Citation: Rm. Stone et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER INITIAL CHEMOTHERAPY FOR ELDERLY PATIENTS WITH PRIMARY ACUTE MYELOGENOUS LEUKEMIA, The New England journal of medicine, 332(25), 1995, pp. 1671-1677
Risultati: 1-25 | 26-45